CAS 361440-67-7 Mama >98.5% (HPLC) Falegaosimea
Ruifu Vailaau Fa'ata'ita'i Fa'atatau
CAS 361442-04-8
CAS 945667-22-1
(R)-1-Boc-3-Aminopiperidine CAS 188111-79-7
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo [3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester CAS 361440-67-7
2-(3-Hydroxy-1-Adamantyl)-2-Oxoacetic Acid CAS 709031-28-7
Igoa Vailaau | (1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester |
Synonyms | N-Boc-L-cis-4,5-Methanoprolineamide;N-Boc-cis-4,5-Methano-L-Prolinamide;tert-Butyl (1S,3S,5S)-3-Carbamoyl-2-Azabicyclo[3.1.0]hexane-2-Carboxylate |
Numera CAS | 361440-67-7 |
CAT Numera | RF-PI1990 |
Tulaga Fa'asoa | I Fa'atauga, Oloa Fua e O'o i Tone |
Fuafua mole | C11H18N2O3 |
Molecular Weight | 226.27 |
Fa'apuna | 388.9±21.0℃ |
Malosi | 1.228 |
Fa'ailoga | Ruifu Chemical |
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'u Pa'epa'e |
Mama / Suʻesuʻega Metotia | >98.5% (HPLC) |
Ma'imau ile Fa'amago | <0.50% |
Toega i luga o le mumu | <0.20% |
Fa'aleaga Ta'ito'atasi | <1.00% |
Aofa'i Fa'aleaga | <1.50% |
Tulaga Su'ega | Pisinisi Tulaga |
Fa'aoga | Intermediate of API (CAS: 361442-04-8) |
afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau
Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu
(1S,3S,5S)-3-(Aminocarbonyl)-2-Azabicyclo[3.1.0]hexane-2-Carboxylic Acid tert-Butyl Ester (CAS: 361440-67-7) ose mea vavalo ole API (CAS: 361442) -04-8).(CAS: 361442-04-8) ose oral hypoglycemic (anti-diabetic drug) o le dipeptidyl peptidase-4 (DPP-4) inhibitor vasega o fualaau.O le amataga o le atina'e sa na'o Bristol-Myers Squibb;i le 2007 AstraZeneca na faʻatasi ma Bristol-Myers Squibb e faʻapipiʻi faʻatasi le vaega mulimuli ma galulue faʻatasi i le maketiina o vailaʻau.Ia Iuni 2008, na faʻasalalau ai o Onglyza o le igoa tau fefaʻatauaʻiga lea o le a faʻatau atu ai.API (CAS: 361442-04-8) e faʻaaogaina e pei o le monotherapy poʻo faʻatasi ma isi vailaʻau mo togafitiga o le maʻisuka ituaiga 2.E vave ona mitiia pe a mae'a le tu'u gutu ma o lo'o i ai se tala'aga pharmacokinetic e fetaui ma le tu'u tasi i le aso.E fa'atino le sao e ala i le taofia o le fa'aleagaina o le GLP-l.GLP-I o hormones e masani ona gaosia i totonu o le manava pe a uma ona 'ai.